Miles B, Mackey JD. Increased Risk of Second Primary Malignancy and Mortality at Ten Years After Stem Cell Transplant for Multiple Myeloma: An Analysis of 14,532 Patients. Cureus. 2021;13(7). doi:10.7759/cureus.16372
Miles B, Mackey JD. The lung cancer obesity paradox: An analysis of 432,924 patients. JCO. 2021;39(15_suppl):10578-10578. doi:10.1200/JCO.2021.39.15_suppl.10578
Miles B, Moth J, Mackey J. Usefulness of nivolumab plus ipilimumab immunotherapy for metastatic uveal melanoma. Proc (Bayl Univ Med Cent). 2020;34(1):118-119. Published
2020 Oct 19. doi:10.1080/08998280.2020.1825587
Miles B, Mackey JD. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Lung Cancer: History, Epidemiology, and Market Outlook. Cureus. 2021;13(2). doi:10.7759/cureus.134701.
Miles B, Armenta A, Mackey J. The Use of Neodymium-Doped Yttrium Aluminum Garnet Laser for Treatment of Hypertrophic Port-Wine Stain. Case Reports in Dermatological Medicine. 2022;2022:e8788417. doi:10.1155/2022/8788417
Miles B, Mackey JD. The Potential Impact of SARS-CoV-2 Infection on Patients with NASH and Liver Fibrosis. Poster presented at: The 6th Paris NASH Meeting; October 22, 2020; Paris, France.
Miles B, Mackey JD. Resensitization to ESA Therapy After Use of a Hypomethylating Agent in Myelodysplastic Syndrome. Poster presented at: Translational Research E-Conference on Bone Marrow Failure Disorders; November 13-15, 2020; Paris, France.
Miles BL, Mackey J. Tyrosine kinase inhibitors and lung cancer: History, epidemiology and market outlook. Annals of Oncolo gy. 2020;31:S1239. doi:10.1016/j.annonc.2020.08.2230
Miles B , Mackey JD. Increased Risk of Second Primary Malignancy and Mortality at Ten Years After Stem Cell Transplant for Multiple Myeloma: An Analysis of 14,532 Patients. Poster presented at: 18th International Myeloma Workshop; September 8-11, 2021; Vienna, Austria.